Latano-Vision Sine

Latanoprost, the active ingredient in Latano-Vision Sine, is a prostaglandin analog presented as a ophthalmic solution for ocular use. It is used to lower intraocular pressure in patients with open-angle glaucoma and ocular hypertension.

GNH USA supplies Latano‑Vision Sine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used in the management of glaucoma and ocular hypertension.

- Open-angle glaucoma: reduces intraocular pressure to slow disease progression. - Ocular hypertension: lowers elevated eye pressure to prevent development of glaucoma. - Secondary open-angle glaucoma: assists in controlling pressure when caused by other ocular conditions.

Latanoprost may cause ocular and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris darkening: gradual brownish pigmentation. - Eye irritation: burning or stinging sensation. - Blurred vision: transient visual disturbance. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Uveitis: inflammation of the uveal tract. - Macular edema: fluid accumulation in the central retina. - Paradoxical increase in intraocular pressure. - Corneal edema: swelling of the cornea affecting clarity.

Before initiating therapy, clinicians should evaluate patient history and monitor ocular health.

- Baseline IOP assessment: record intraocular pressure prior to treatment. - Iris pigmentation monitoring: observe for color changes over time. - History of uveitis: avoid use if active inflammation is present. - Ocular infection caution: defer treatment until infection resolves. - Hypersensitivity screening: discontinue if allergic signs appear. - Store at room temperature: keep in original container, protect from moisture and light.

Latanoprost may interact with other ocular or systemic agents, affecting efficacy or safety.

Major Interactions (Avoid): - Concurrent use with other prostaglandin analog eye drops: may increase risk of ocular irritation. - Simultaneous administration of ocular anesthetics: can exacerbate corneal toxicity. - Use with systemic carbonic anhydrase inhibitors: may lead to excessive IOP reduction.

Moderate Interactions (Monitor Closely): - Combination with beta‑blocker eye drops: monitor for additive IOP‑lowering effect. - Co‑administration with non‑steroidal anti‑inflammatory eye drops: may reduce prostaglandin activity. - Use with systemic corticosteroids: watch for delayed wound healing after ocular surgery.